Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Public ClinicalTrials.gov record NCT01892722. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Study identification
- NCT ID
- NCT01892722
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 240 participants
Conditions and interventions
Conditions
Interventions
- Interferon beta-1a Drug
- Fingolimod Drug
- Placebo capsule Drug
- Placebo i.m. injection Drug
Drug
Eligibility (public fields only)
- Age range
- 10 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 25, 2013
- Primary completion
- Jul 13, 2017
- Completion
- Feb 17, 2030
- Last update posted
- Jun 7, 2026
2013 – 2030
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB Childrens Hospital Harbor Center Neurology Dept | Birmingham | Alabama | 35294 | — |
| Childrens Hospital Los Angeles | Los Angeles | California | 90027 | — |
| UCSF | San Francisco | California | 94115 | — |
| University of Miami | Miami | Florida | 33136 | — |
| AMO Corporation | Tallahassee | Florida | 32312 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Wayne State University | Detroit | Michigan | 48201 | — |
| Robert Wood Johnson Medical School | New Brunswick | New Jersey | 08901 | — |
| Childrens Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 4399 | — |
| University of Utah Clinical Trials Office | Salt Lake City | Utah | 84108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 63 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01892722, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 7, 2026 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01892722 live on ClinicalTrials.gov.